or Try an Advanced Search...

    Technical Analysis for ONCO - Onconetix, Inc.

    Grade Last Price % Change Price Change
    F 2.90 0.35% 0.01
    ONCO closed up 0.35 percent on Friday, November 1, 2024, on 4 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical ONCO trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 0.35%
    NR7 Range Contraction 0.35%
    Narrow Range Bar Range Contraction 0.35%
    Doji - Bullish? Reversal 0.35%
    Lower Bollinger Band Walk Weakness 0.35%
    Older End-of-Day Signals for ONCO ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 21 hours ago
    Up 3% about 24 hours ago
    Up 2% about 24 hours ago
    Up 1% about 24 hours ago
    Fell Below Previous Day's Low 2 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    ONCO Chart by TradingView
    Basic chart:

    Profile

    Onconetix, Inc. (formerly Blue Water Biotech, Inc. (BWV)) is a commercial stage biotechnology company focused on the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The Company currently has Entadfi®, an FDA approved, oral therapeutic for the treatment of benign prostatic hyperplasia (BPH), a disorder of the prostate, and Proclarix®, an advanced proprietary diagnostic system for screening and diagnosis for men with indeterminate Prostate Specific Antigen (PSA) assessments in prostate cancer oncology.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology FDA Disorders Prostate Cancer Urology Benign Prostatic Hyperplasia Bph Men's Health Prostate Treatment Of Benign Prostatic Hyperplasia

    Is ONCO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 3 Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit
    Oct 3 Onconetix announces $2M private placement, and establishes $25M equity line of credit
    Oct 3 Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit
    Sep 27 Crude Oil Rises; Onconetix Shares Spike Higher
    Sep 27 Onconetix rallies after Altos Venture reports 32.5% stake
    Sep 27 Dow Surges Over 100 Points; Costco Earnings Top Views
    Sep 20 Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders
    Jul 22 Why Tellurian Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket
    Jul 19 Why Intuitive Surgical Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
    Jul 18 US Stocks Edge Higher; D.R. Horton Posts Upbeat Earnings
    See more ONCO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 21.4
    52 Week Low 2.844
    Average Volume 817,580
    200-Day Moving Average 5.99
    50-Day Moving Average 4.80
    20-Day Moving Average 4.70
    10-Day Moving Average 3.91
    Average True Range 0.54
    RSI (14) 32.89
    ADX 34.4
    +DI 22.69
    -DI 33.93
    Chandelier Exit (Long, 3 ATRs) 4.89
    Chandelier Exit (Short, 3 ATRs) 4.46
    Upper Bollinger Bands 6.88
    Lower Bollinger Band 2.51
    Percent B (%b) 0.09
    BandWidth 93.04
    MACD Line -0.53
    MACD Signal Line -0.26
    MACD Histogram -0.2754
    Fundamentals Value
    Market Cap 64.74 Million
    Num Shares 22.3 Million
    EPS
    Price-to-Sales 0.00
    Price-to-Book 0.36
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.08
    Resistance 3 (R3) 3.09 3.05 3.05
    Resistance 2 (R2) 3.05 3.00 3.04 3.04
    Resistance 1 (R1) 2.97 2.97 2.95 2.96 3.03
    Pivot Point 2.93 2.93 2.92 2.92 2.93
    Support 1 (S1) 2.85 2.88 2.83 2.84 2.77
    Support 2 (S2) 2.81 2.85 2.80 2.76
    Support 3 (S3) 2.73 2.81 2.75
    Support 4 (S4) 2.72